PDS Biotechnology (PDSB) Total Current Liabilities (2014 - 2026)
PDS Biotechnology (PDSB) reported Total Current Liabilities of $12.38 million for Q2 2026, up 7.3% from $11.53 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Total Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, PDS Biotechnology posted Total Current Liabilities of $9.48 million, down 44.5% from FY2024.
- Total Current Liabilities has a five-year compound annual growth rate of 23.7% (FY2020 to FY2025).
- By year, Total Current Liabilities came in at $17.09 million in FY2024 (+25.4%), $13.63 million in FY2023 (+38.8%), $9.82 million in FY2022 (+161.5%) and $3.76 million in FY2021 (+14.8%).
- Five-year quarterly Total Current Liabilities spans a low of $3.58 million in Q3 2021 and a high of $18.34 million in Q3 2024.
- Year over year, Total Current Liabilities gained in four of the last seven quarters, with growth averaging 8.0%.
- The high point for year-over-year Total Current Liabilities in five years was Q1 2024 (growth of 264.8%); the low point was Q4 2025 (a decline of 44.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | PDS Biotechnology | 43.06 Mn | 43.06 Mn | - | 12.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.38 Mn |
| Dec 31, 2025 | 9.48 Mn |
| Sep 30, 2025 | 13.33 Mn |
| Jun 30, 2025 | 11.53 Mn |
| Mar 31, 2025 | 18.27 Mn |
| Dec 31, 2024 | 17.09 Mn |
| Sep 30, 2024 | 18.34 Mn |
| Jun 30, 2024 | 15.67 Mn |
| Mar 31, 2024 | 15.06 Mn |
| Dec 31, 2023 | 13.63 Mn |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 9.82 Mn |
| Sep 30, 2022 | 4.84 Mn |
| Jun 30, 2022 | 4.52 Mn |
| Mar 31, 2022 | 5.02 Mn |
| Dec 31, 2021 | 3.76 Mn |
| Sep 30, 2021 | 3.58 Mn |
| Jun 30, 2021 | 4.00 Mn |
API Access
PDS Biotechnology Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();